{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:56:48Z","timestamp":1792587408707,"version":"4.5.0"},"reference-count":118,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,3,19]],"date-time":"2010-03-19T00:00:00Z","timestamp":1268956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2010,5]]},"abstract":"<jats:p>Glycogen synthase kinase\u20103 beta (GSK3\u03b2) is a multifunctional serine\/threonine kinase which was originally identified as a regulator of glycogen metabolism. It plays a key role in the regulation of numerous signalling pathways including cellular process such as cell cycle, inflammation and cell proliferation. Over the last few years there is a considerable rise in the number of journals and patents publication by different workers worldwide. Many pharmaceutical companies are focusing on GSK3\u03b2 as a therapeutic target for the treatment of disease conditions. The present review is focused on signalling pathways of different disease conditions where GSK3\u03b2 is implicated. In this review, we present a comprehensive map of GSK3\u03b2 signalling pathways in disease physiologies. Structural analysis of GSK3\u03b2 along with molecular modelling reports from numerous workers are reviewed in context of design and development of GSK3\u03b2 inhibitors. Patent landscape of the small molecule modulators is profiled. The chemo space for small molecule modulators extracted from public and proprietary Kinase Chembiobase for GSK3\u03b2 are discussed. Compounds in different clinical phases of discovery are analysed. The review ends with the overall status of this important therapeutic target and challenges in development of its modulators.<\/jats:p>","DOI":"10.1111\/j.1476-5381.2010.00661.x","type":"journal-article","created":{"date-parts":[[2010,3,20]],"date-time":"2010-03-20T23:09:34Z","timestamp":1269126574000},"page":"1-19","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":145,"title":["GSK3\u03b2: role in therapeutic landscape and development of modulators"],"prefix":"10.1111","volume":"160","author":[{"given":"S","family":"Phukan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VS","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kannoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Hariharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VN","family":"Balaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,4,13]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1124\/mi.8.5.8"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2008.06.001"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2004.11.022"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/28.1.235"},{"key":"e_1_2_12_6_1","doi-asserted-by":"crossref","first-page":"11074","DOI":"10.1073\/pnas.190297597","article-title":"l Regulationand localization of tyrosine216 phosphorylation of glycogen synthase kinase\u20103beta in cellular and animal models of neuronal degeneration","volume":"97","author":"Bhat RV","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M306268200"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.11.003"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0083-6729(08)00619-5"},{"key":"e_1_2_12_10_1","unstructured":"BussiereDE HeM LeVP JansenJM ChinS MartinE(2002).Charaterisation of GSK3\u03b2 protein and methods of use thereof. WO 02\/24893 A2."},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cr.7310078"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2003.02088.x"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2000.0721327.x"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.10.2903"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0014-2956.2001.02473.x"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(97)00490-0"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/35096075"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(02)00215-0"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/348302a0"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.12.22.3499"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2007.04.001"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.00384"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00547.2004"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1296"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1980.tb06059.x"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.3389\/neuro.02.002.2009"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00244.2007"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0802907"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj3590001"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.10.3.429"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(01)00253-2"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(02)02278-7"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1021\/ci6005036"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.20726"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.10.3.377"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1210\/me.2007-0129"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.1.21"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(92)90774-2"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000018952.70505.F1"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2008.10.026"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2002.01269.x"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.31.19547"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2003.01987.x"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.06.055"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1508"},{"key":"e_1_2_12_46_1","unstructured":"JoongMC RoS LeeTG LeeKJ ShinD HyunY\u2010Let\u2003al.(2004).Glycogen synthase kinase 3beta inhibitor composition and process for the preparation thereof. WO 04\/065370 A1."},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389450110607011421"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2007.12.002"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.12.11.1443"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2007.01.004"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990827)82:5<625::AID-IJC1>3.0.CO;2-2"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2006.10.031"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.16.8455"},{"key":"e_1_2_12_54_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.26.3.898-911.2006"},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.5.9.3151"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-05-0258"},{"key":"e_1_2_12_57_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1014503604270"},{"key":"e_1_2_12_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20691"},{"key":"e_1_2_12_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/qsar.200730052"},{"key":"e_1_2_12_60_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2121-9-11"},{"key":"e_1_2_12_61_1","first-page":"6583","article-title":"ErbB2\/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways","volume":"61","author":"Lenferink AE","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_12_62_1","doi-asserted-by":"publisher","DOI":"10.4161\/cc.2.4.433"},{"key":"e_1_2_12_63_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-1519"},{"key":"e_1_2_12_64_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000061762.58873.2F"},{"key":"e_1_2_12_65_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2002.00939.x"},{"key":"e_1_2_12_66_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm040895g"},{"key":"e_1_2_12_67_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2008-15204"},{"key":"e_1_2_12_68_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0808315106"},{"key":"e_1_2_12_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2111"},{"key":"e_1_2_12_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2003.11.010"},{"key":"e_1_2_12_71_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-008-0828-5"},{"key":"e_1_2_12_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2006.05.001"},{"key":"e_1_2_12_73_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M103166200"},{"key":"e_1_2_12_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2008.25"},{"key":"e_1_2_12_75_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.7.2190"},{"key":"e_1_2_12_76_1","doi-asserted-by":"publisher","DOI":"10.1215\/15228517-2008-041"},{"key":"e_1_2_12_77_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1734137100"},{"key":"e_1_2_12_78_1","unstructured":"PascalG AlistairL MouradS FranckS PhilippeY(2004).Substituted 8\u2032\u2010pyridinyl\u2010dihydrospiro\u2010(cycloalkyl)\u2010pyrimido (1 2\u2010a)pyrimidin\u20106\u2010one and 8\u2032\u2010pyrimidinyl\u2010dihydrospiro\u2010(cycloalkyl)\u2010pyrimido (1 2\u2010a) pyrimidin\u20106\u2010one derivatives and their use against neurogenerative diseasesWO 04\/078760 A1."},{"key":"e_1_2_12_79_1","unstructured":"PatriciaA DayL LeyiG(2003).Use of a GSK3\u03b2 inhibitor in the manufacture of a medicament for increasing bone formation methods for increasing bone formation. WO 03\/057202 A1."},{"key":"e_1_2_12_80_1","doi-asserted-by":"publisher","DOI":"10.2174\/138920307781369409"},{"key":"e_1_2_12_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2008.10.013"},{"key":"e_1_2_12_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.2"},{"key":"e_1_2_12_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2007.01.029"},{"key":"e_1_2_12_84_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.41.1.789"},{"key":"e_1_2_12_85_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm050504d"},{"key":"e_1_2_12_86_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-325"},{"key":"e_1_2_12_87_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-008-9244-1"},{"key":"e_1_2_12_88_1","first-page":"244","article-title":"Mechanism of tau hyperphosphorylation in brain cortex of diabetic rats and effect of LiCl","volume":"28","author":"Qu ZS","year":"2006","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"e_1_2_12_89_1","unstructured":"RaymondJA MichelR JasbinderS DannyL(1999).Granulatimide derivatives for use in cancer treatment. WO 99\/47522 A1."},{"key":"e_1_2_12_90_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.3.588"},{"key":"e_1_2_12_91_1","doi-asserted-by":"publisher","DOI":"10.1139\/y05-142"},{"key":"e_1_2_12_92_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2123"},{"key":"e_1_2_12_93_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.289.5481.950"},{"key":"e_1_2_12_94_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200505078"},{"key":"e_1_2_12_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2003.11.014"},{"key":"e_1_2_12_96_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2001.6305"},{"key":"e_1_2_12_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1999.tb00777.x"},{"key":"e_1_2_12_98_1","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E05-07-0688"},{"key":"e_1_2_12_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.07.041"},{"key":"e_1_2_12_100_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M413056200"},{"key":"e_1_2_12_101_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M201919200"},{"key":"e_1_2_12_102_1","unstructured":"ShudongW ChristopherM GavinW KennethD DaniellaZ PeterF(2004).Therapeutic applications of 2\u2010substituted 4\u2010heteroarylpyrimidines. WO 04\/056368 A1."},{"key":"e_1_2_12_103_1","unstructured":"ShudongW JaniceM DarrenG AshleyC NicholasT PeterF(2005).2\u2010Aminophenyl\u20104\u2010phenylpyrimidines as kinase inhibitors. WO 05\/012262 A1."},{"key":"e_1_2_12_104_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M406294200"},{"key":"e_1_2_12_105_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707659"},{"key":"e_1_2_12_106_1","doi-asserted-by":"publisher","DOI":"10.3109\/10799899809047746"},{"key":"e_1_2_12_107_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2006-9S335"},{"key":"e_1_2_12_108_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M512722200"},{"key":"e_1_2_12_109_1","unstructured":"ThierryG PatrickL AlistairL SeverineM AlainN MouradSet\u2003al.(2003).Substituted\u20102\u2010pyridinyl\u20106 7 8 9\u2010tetrahydropyrimido(1 2\u2010a)pyrimidin\u20104\u2010one and 7\u2010pyridinyl\u20102 3\u2010dihydroimidazo(1 2\u2010a)pyrimidin\u20105(1H)one derivatives. WO 03\/027116 A2."},{"key":"e_1_2_12_110_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/22.22.4673"},{"key":"e_1_2_12_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2006.03.013"},{"key":"e_1_2_12_112_1","doi-asserted-by":"crossref","unstructured":"ToshiyukiK KenjiF TokushiH(2004).Dihydropyrazolopyridine compounds. WO 04\/014910 A1.","DOI":"10.1201\/9780203641965.pt1"},{"key":"e_1_2_12_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2004.09.004"},{"key":"e_1_2_12_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2008.12.013"},{"key":"e_1_2_12_115_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M206306200"},{"key":"e_1_2_12_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(03)00287-9"},{"key":"e_1_2_12_117_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2007-1142"},{"key":"e_1_2_12_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2008.10.014"},{"key":"e_1_2_12_119_1","doi-asserted-by":"publisher","DOI":"10.4161\/cc.4.6.1744"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2010.00661.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2010.00661.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T19:10:26Z","timestamp":1697397026000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2010.00661.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,13]]},"references-count":118,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["10.1111\/j.1476-5381.2010.00661.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00661.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,13]]},"assertion":[{"value":"2010-04-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}